Professor Bart De Strooper is the founding director of the UK Dementia Research Institute (UK DRI).
He is a researcher in Alzheimer's disease, and supervises laboratories based in the UK DRI at the Francis Crick Institute in London and in the VIB laboratory at the KU Leuven in Belgium.
Bart De Strooper’s research is focussed on translating genetic findings into mechanisms of neurodegenerative diseases and drug targets. He is best known for his work on the presenilins and gamma-secretase, and more recently for his work on the cellular theory of Alzheimer’s Disease. He was elected to the Academy of Medical Sciences Fellowship in 2020, and has received several awards including the Potamkin prize, the Metlife Foundation Award for Medical Research, Alois Alzheimer’s prize, the highly prestigious Brain Prize 2018 and Commander in the Order of Leopold I.